For example, miR-18a enhanced PD-L1 expression in cervical cancer by targeting the tumor suppressor PTEN and the Wnt/β-catenin pathway inhibitor SOX6 to activate the PI3K/AKT, MEK/ERK and Wnt/β-catenin pathways, respectively [111]. This evidence concerns the gene CD274 and cervical carcinoma.